Olinciguat, an Oral sGC Stimulator, Exhibits Diverse Pharmacology Across Preclinical Models of Cardiovascular, Metabolic, Renal, and Inflammatory Disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Olinciguat, an Oral sGC Stimulator, Exhibits Diverse Pharmacology Across Preclinical Models of Cardiovascular, Metabolic, Renal, and Inflammatory Disease
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-04-08
DOI
10.3389/fphar.2020.00419
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An exploratory, randomised, placebo-controlled, 14 day trial of the soluble guanylate cyclase stimulator praliciguat in participants with type 2 diabetes and hypertension
- (2019) John P. Hanrahan et al. DIABETOLOGIA
- cGMP at the centre of attention: emerging strategies for activating the cardioprotective PKG pathway
- (2018) Min Park et al. BASIC RESEARCH IN CARDIOLOGY
- Vascular smooth muscle cell proliferation as a therapeutic target. Part 1: molecular targets and pathways
- (2018) Dongdong Wang et al. BIOTECHNOLOGY ADVANCES
- Captopril Attenuates Cardiovascular and Renal Disease in a Rat Model of Heart Failure With Preserved Ejection Fraction
- (2018) Eman M. Salah et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Pharmacological Characterization of IW-1973, a Novel Soluble Guanylate Cyclase Stimulator with Extensive Tissue Distribution, Antihypertensive, Anti-Inflammatory, and Antifibrotic Effects in Preclinical Models of Disease
- (2018) Jenny V. Tobin et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Discovery and development of next generation sGC stimulators with diverse multidimensional pharmacology and broad therapeutic potential
- (2018) E.S. Buys et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- Tadalafil induces antiproliferation, apoptosis, and phosphodiesterase type 5 downregulation in idiopathic pulmonary arterial hypertension in vitro
- (2017) Aya Yamamura et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Characterization of liver changes in ZSF1 rats, an animal model of metabolic syndrome
- (2017) Marta Borges Canha et al. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
- High resolution molecular and histological analysis of renal disease progression in ZSF1 fa/faCP rats, a model of type 2 diabetic nephropathy
- (2017) Ken Dower et al. PLoS One
- Discovery of IWP-051, a Novel Orally Bioavailable sGC Stimulator with Once-Daily Dosing Potential in Humans
- (2016) Takashi Nakai et al. ACS Medicinal Chemistry Letters
- Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction
- (2016) Constantijn Franssen et al. JACC-Heart Failure
- Renal effects of soluble guanylate cyclase stimulators and activators: A review of the preclinical evidence
- (2015) Johannes-Peter Stasch et al. CURRENT OPINION IN PHARMACOLOGY
- PATENT PLUS: a blinded, randomised and extension study of riociguat plus sildenafil in pulmonary arterial hypertension
- (2015) Nazzareno Galiè et al. EUROPEAN RESPIRATORY JOURNAL
- Stimulation of soluble guanylyl cyclase protects against obesity by recruiting brown adipose tissue
- (2015) Linda S. Hoffmann et al. Nature Communications
- Treatment of Pulmonary Hypertension Caused by Left Heart Failure With Pulmonary Arterial Hypertension–Specific Therapies
- (2013) Lewis J. Rubin CIRCULATION
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
- (2013) Neil J. Stone et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
- (2013) Hossein-Ardeschir Ghofrani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Riociguat for the Treatment of Pulmonary Arterial Hypertension
- (2013) Hossein-Ardeschir Ghofrani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structure and Regulation of Soluble Guanylate Cyclase
- (2012) Emily R. Derbyshire et al. Annual Review of Biochemistry
- Inhibition of nitric oxide synthesis enhances leukocyte rolling and adhesion in human microvasculature
- (2012) Mokarram Hossain et al. Journal of Inflammation-London
- TRC150094 attenuates progression of nontraditional cardiovascular risk factors associated with obesity and type 2 diabetes in obese ZSF1 rats
- (2012) Shitalkumar Zambad et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Diabetic nephropathy and long-term treatment effects of rosiglitazone and enalapril in obese ZSF1 rats
- (2011) Victor P Bilan et al. JOURNAL OF ENDOCRINOLOGY
- Soluble Guanylate Cyclase Stimulation Prevents Fibrotic Tissue Remodeling and Improves Survival in Salt-Sensitive Dahl Rats
- (2011) Sandra Geschka et al. PLoS One
- Discovery of Riociguat (BAY 63-2521): A Potent, Oral Stimulator of Soluble Guanylate Cyclase for the Treatment of Pulmonary Hypertension
- (2009) Joachim Mittendorf et al. ChemMedChem
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More